Medpace Holdings, Inc. Deferred Income Tax Liabilities, Net
Medpace Holdings, Inc. (MEDP) had Deferred Income Tax Liabilities, Net of $8.21 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-07-23
- 2026-06-30: Deferred Income Tax Liabilities, Net $8.21M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $3.92M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $1.35M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $1.90M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $8.21M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $3.92M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $1.35M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $1.90M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $2.02M 10-Q · filed 2025-07-22 |
| 2025-03-31 | $1.84M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $1.80M 10-K · filed 2026-02-10 |
| 2024-09-30 | $2.29M 10-Q · filed 2024-10-22 |
| 2024-06-30 | $2.29M 10-Q · filed 2024-07-23 |
| 2024-03-31 | $2.36M 10-Q · filed 2024-04-23 |
| 2023-12-31 | $2.40M 10-K · filed 2025-02-11 |
| 2023-09-30 | $1.13M 10-Q · filed 2023-10-24 |
| 2023-06-30 | $1.10M 10-Q · filed 2023-07-25 |
| 2023-03-31 | $1.09M 10-Q · filed 2023-04-25 |
| 2022-12-31 | $1.07M 10-K · filed 2024-02-13 |
| 2022-09-30 | $911.00K 10-Q · filed 2022-10-25 |
| 2022-06-30 | $1.00M 10-Q · filed 2022-07-26 |
| 2022-03-31 | $1.05M 10-Q · filed 2022-04-26 |
| 2021-12-31 | $1.08M 10-K · filed 2023-02-14 |
| 2021-09-30 | $17.60M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $16.24M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $14.88M 10-Q · filed 2021-04-27 |
| 2020-12-31 | $13.55M 10-K · filed 2022-02-15 |
| 2020-09-30 | $19.86M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $15.34M 10-Q · filed 2020-07-28 |
| 2019-12-31 | $12.85M 10-K · filed 2021-02-16 |
| 2019-01-01 | $3.16M 10-K · filed 2022-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |